Possible Influence of Oxidative Stress on Development of Raynaud Phenomenon in Patients With CREST Scleroderma Syndrome

1. Velayos EE, Masi AT, Stevens MB, Shulman LE. The 'CREST' syndrome. Comparison with systemic sclerosis (scleroderma). Arch Intern Med. 1979;139(11):1240-4.10.1001/archinte.1979.03630480030012Search in Google Scholar

2. Merlino G, Germano S, Carlucci S. Surgical management of digital calcinosis in CREST syndrome. Aesthetic Plast Surg. 2013;37(6):1214-9.2414211410.1007/s00266-013-0224-z24142114Search in Google Scholar

3. Cutler TS, Reyentovich A. Peripheral phenomena in a woman with calcinosis, Raynaud phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia (CREST) syndrome-associated pulmonary hypertension. Circulation. 2012;125(9):e413-4.10.1161/CIRCULATIONAHA.111.05413022392867Search in Google Scholar

4. Shenavandeh S. Calcinosis universalis in a patient with overlap of scleroderma/dermatomyositis. J Clin Rheumatol. 2012;18(1):57.10.1097/RHU.0b013e31823ee76722198488Search in Google Scholar

5. Duzgun N. Cutaneous calcinosis in a patient with limited scleroderma: CREST Syndrome. Eur J Rheumatol. 2017;4(4):305-6.10.5152/eurjrheum.2017.17034574134829308290Open DOISearch in Google Scholar

6. Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med. 2009;360(19):1989-2003.10.1056/NEJMra080618819420368Search in Google Scholar

7. Simonini G, Cerinic MM, Generini S, Zoppi M, Anichini M, Cesaretti C, et al. Oxidative stress in systemic sclerosis. Mol Cell Biochem. 1999;196(1-2):85-91.10.1023/A:1006922313774Search in Google Scholar

8. Mylonas C, Kouretas D. Lipid peroxidation and tissue damage. In Vivo. 1999;13(3):295-309.Search in Google Scholar

9. Ayala A, Munoz MF, Arguelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev. 2014;2014:360438.10.1155/2014/360438406672224999379Search in Google Scholar

10. Herrick AL. Pathogenesis of Raynaud’s phenomenon. Rheumatology (Oxford). 2005;44(5):587-96.1574120010.1093/rheumatology/keh55215741200Search in Google Scholar

11. Balbir-Gurman A, Braun-Moscovici Y, Livshitz V, Schapira D, Markovits D, Rozin A, et al. Antioxidant status after iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis. Clin Rheumatol. 2007; 26(9):1517-21.10.1007/s10067-007-0613-217401513Open DOISearch in Google Scholar

12. Johnson JM, Yen TC, Zhao K, Kosiba WA. Sympathetic, sensory, and nonneuronal contributions to the cutaneous vasoconstrictor response to local cooling. Am J Physiol Heart Circ Physiol. 2005;288(4):H1573-9.10.1152/ajpheart.00849.2004Search in Google Scholar

13. Yamazaki F, Sone R, Zhao K, Alvarez GE, Kosiba WA, Johnson JM. Rate dependency and role of nitric oxide in the vascular response to direct cooling in human skin. J Appl Physiol. 2006;100(1):42-50.10.1152/japplphysiol.00139.2005Search in Google Scholar

14. Matucci Cerinic M, Kahaleh MB. Beauty and the beast. The nitric oxide paradox in systemic sclerosis. Rheumatology. 2002;41(8):843-7.10.1093/rheumatology/41.8.843Search in Google Scholar

15. Maricq HR, Valter I. A working classification of scleroderma spectrum disorders: a proposal and the results of testing on a sample of patients. Clin Exp Rheumatol. 2004;22(3 Suppl 33):S5-13.Search in Google Scholar

16. Murrel DF. A radical proposal for the pathogenesis of scleroderma. J Am Acad Dermatol. 1993;28(1):78-85.10.1016/0190-9622(93)70014-KOpen DOISearch in Google Scholar

17. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human diseases. Int J Biochem Cell Biol. 2007;39(1):44-84.10.1016/j.biocel.2006.07.001Open DOISearch in Google Scholar

18. Granger DN. Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol. 1988;255(6 Pt 2):H1269-75.10.1152/ajpheart.1988.255.6.H1269Search in Google Scholar

19. Gabrielli A, Svegliati S, Moroncini G, Amico D. New insights into the role of oxidative stress in scleroderma fibrosis. Open Rheum J. 2012;6(Suppl 1: M4):87-95.10.2174/1874312901206010087Search in Google Scholar

20. Bedard K, Krause KH. The nox family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev. 2007;87(1):245-313.10.1152/physrev.00044.2005Search in Google Scholar

21. Sambo P, Baroni SS, Luchetti M, Paroncini P, Dusi S, Orlandini G, et al. Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway. Arthritis Rheum. 2001;44(11):2653-64.10.1002/1529-0131(200111)44:11<2653::AID-ART445>3.0.CO;2-1Search in Google Scholar